Women who started menstruating at the age of 11 or younger, or entered menopause before 47, face a higher risk of heart disease and stroke, according to a study published Tuesday.
This content was originally published here.
Post Views: 716
Women who started menstruating at the age of 11 or younger, or entered menopause before 47, face a higher risk of heart disease and stroke, according to a study published Tuesday.
This content was originally published here.
On July 17, 2025, the U.S. Food and Drug Administration (FDA) hosted a landmark expert panel to address longstanding controversies surrounding hormone replacement therapy (HRT)
Dr. Howard Hodis, professor of medicine and a landmark figure in cardiovascular research, delivered a thorough analysis of how HRT timing determines its effect profile.
Dr. Rachel S. Rubin, fellowship-trained urologist and sexual medicine expert, used her time to elevate the discussion around genital and urinary syndrome of menopause (GSM).
Mary Jane Minkin, MD, veteran OB/GYN and menopause educator, presented a comprehensive critique of the “one-size-fits-all” black box warning on estrogen therapies, focusing especially on
Dr. Kelly Casperson brought a unique perspective as a urologist and sexual health expert, focusing attention on the regulatory and clinical neglect faced by women
Dr. Vonda Wright, a leading authority on musculoskeletal health and aging, offered a no-nonsense appraisal of estrogen’s role in maintaining bone health after menopause. Describing
Supported by:
The Menopause Association
4301 50th Street NW
Suite 300-1090
Washington, DC 20013
FOR WOMEN
FOR PROVIDERS
REDEFINING MENOPAUSE
The Menopause Association is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.
© - Redefining Menopause Provided by The Menopause Association | Platinum Media Solutions | All rights reserved